Page last updated: 2024-10-22

apraclonidine and Day Blindness

apraclonidine has been researched along with Day Blindness in 2 studies

apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burnstein, Y1
Shelton, K1
Higginbotham, EJ1
Vocci, MJ1
Robin, AL1
Wahl, JC1
Mayer, P1
Graves, A1
York, B1
Enger, C1
Sutton, J1

Trials

1 trial available for apraclonidine and Day Blindness

ArticleYear
Reformulation and drop size of apraclonidine hydrochloride.
    American journal of ophthalmology, 1992, Feb-15, Volume: 113, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Double-Blind Method; Female; Formularies as Topic; Huma

1992

Other Studies

1 other study available for apraclonidine and Day Blindness

ArticleYear
Glaucomatocyclitic crisis in a child.
    American journal of ophthalmology, 1998, Volume: 126, Issue:1

    Topics: Adolescent; Clonidine; Corneal Edema; Diagnosis, Differential; Drug Therapy, Combination; Glaucoma;

1998